33 min listen
Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care?
FromKeeping Current
ratings:
Length:
36 minutes
Released:
Dec 21, 2021
Format:
Podcast episode
Description
Join 3 experts in discussion about the potential role of dual incretin agonist peptides in patients with type 2 diabetes. Credit available for this activity expires: 12/20/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/964951?src=mkm_podcast_addon_964951
Released:
Dec 21, 2021
Format:
Podcast episode
Titles in the series (100)
How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease?: Join Drs Distler and Hoffmann-Vold as they discuss current and emerging treatments for SSc-ILD and their clinical impact --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current